Option chain shows key data for Cartica Acq's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Cartica Acq.

Cartica Acq (NASDAQ:CITEW) Stock, Option Chain

Cartica Acquisition Corp is a blank check company.

Cartica Acquisition Corp

Merck (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>), known as MSD outside the United States and Canada, has been notified that TRC Capital Investment Corporation (TRC Capital) has commenced an unsolicited "mini-tender" offer, dated November 12, 2024, to purchase up to 1,000,000 shares of Merck common stock at $96.38 per share. The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024 ($100.73), the last trading day before the date of the offer, and approximately 3.48% below the closing price of the Merck common stock on November 21, 2024 ($99.86), the day prior to this release.
Merck does not endorse TRC Capital's offer and recommends that Merck shareholders reject the offer and not tender their shares in response to TRC Capital's unsolicited mini-tender offer. This mini-tender offer is at a price below the closing price for Merck's shares (as of the day prior to this release) and is subject to numerous conditions, including TRC Capital's ability to obtain financing. Merck is not associated in any way with TRC Capital, its mini-tender offer or the offer documentation.

News

Management

Merck Recommends Rejection Of TRC Capital's "Mini-Tender" Offer To Purchase Up To 1M Shares Of Common Stock At $96.38 Per Share

The Las Vegas Grand Prix kicked off with an unexpected twist this week at <a href="https://www.benzinga.com/markets/cannabis/24/04/38181178/exclusive-fifteen-new-f1-hybrid-cannabis-strains-to-hit-shelves-in-us-for-420-under-new-partners">Formula 1</a>. During the second free practice session, it wasn't the usual track talk about lap times or track conditions being discussed by the drivers. Instead, they were commenting on the pervasive cannabis aroma filling the air around the circuit.
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41403643/cannabis-can-be-a-great-tool-in-dealing-with-adversity-says-former-nfl-star-ricky-williams">Cannabis Can Be A &#8216;Great Tool In Dealing With Adversity,&#8217; Says Former NFL Star Ricky Williams</a>
The first to bring it up was young Argentine driver Colapinto. After his media interview following practice, he made a candid observation that quickly went viral.
"Yes, there was a smell of weed. If they do a doping test on the drivers now, I think everyone would test positive, I swear," Colapinto joked. 
"When we all test positive, it'll be a mess," the 21-year-old William&#8217;s driver said in a playful tone.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Insólito comentario de Colapinto: &quot;Sí, había olor a porro&quot; &#x7C; Cadena 3 Argentina" width="500" height="281" src="https://www.youtube.com/embed/Gta2uN9RYpg?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Colapinto wasn't alone in noticing the cannabis scent. Red Bull's Sergio &#8220;Checo&#8221; Pérez also weighed in, concerned about the track conditions: &#8220;Practice 1 was a total disaster, the track was very dirty.&#8221;
<a href="https://www.infobae.com/deportes/2024/11/22/habia-olor-a-porro-la-desopilante-revelacion-de-franco-colapinto-tras-sus-primeras-vueltas-en-el-gran-premio-de-las-vegas/">According </a>to Infobae, he quickly added: "What's really noticeable around the whole circuit is the smell of marijuana all night long. I'm a little tired of it, the amount of odor is unbelievable. It's something that all the drivers will surely talk about."
<h3 class="wp-block-heading">Cannabis In Las Vegas: What You Need to Know</h3>
Since recreational cannabis became legal in Nevada in 2017, adults 21 and over can legally possess up to 2.5 ounces of cannabis flower or 0.25 ounces of THC concentrate, including edibles. 
However, while cannabis use is widespread in the city, public consumption remains off-limits. Smoking or using cannabis in public places is prohibited, with consumption confined to private residences or licensed lounges.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/08/40558915/will-cannabis-be-a-game-changer-for-athletes-nfls-1m-study-suggests-it-could">Will Cannabis Be A Game-Changer For Athletes? NFL&#8217;s $1M Study Suggests It Could</a></li>
</ul>
Image created using photos from Shutterstock and Unsplash.

Cannabis

Sports

Markets

General

Formula 1 Drivers React To Cannabis Smell At Las Vegas Grand Prix: 'Everyone Would Test Positive'

Macquarie analyst Tim Nollen maintains Warner Music Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) with a Neutral and maintains $30 price target.

Price Target

Analyst Ratings

Macquarie Maintains Neutral on Warner Music Gr, Maintains $30 Price Target

The Board of Directors of Cornerstone Strategic Value Fund, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLM#NYSE">CLM</a>) (CUSIP: 21924B302) ("CLM") has approved a change to the name of CLM. This change will become effective December 6, 2024.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
CLM's name will change from "Cornerstone Strategic Value Fund, Inc." to "Cornerstone Strategic Investment Fund, Inc." There will be no changes to CLM's investment objective, investment policies or restrictions in connection with this name change. In addition, CLM's ticker symbol and CUSIP number will not change.

Cornerstone Strategic Value Fund, Inc. Announces Name Change To The Name Of CLM

The Company is committed to completing a deliberate, thorough investigation while diligently working to fulfill all reporting obligations and currently expects to file the Form 10-Q within the six-month period granted by the NYSE Notice; however, there can be no assurance that the Form 10-Q will be filed within such period.

Universal Corporation Receives NYSE Notice Regarding Filing Of Form 10-Q

Community Health Systems To Sell Shorepoint Health System In Florida To AdventHealth For $265M; Deal Includes Port Charlotte And Punta Gorda Facilities, Closing Expected Q1 2025

Legal and political dynamics intensified as President-elect Donald Trump secured a delay in his New York sentencing on felony counts of falsifying business records, while his legal team pushes for dismissal under <a href="https://www.benzinga.com/topic/donald-trump">presidential immunity protections. </a>
The case, stemming from payments tied to adult film actress Stormy Daniels during the 2016 election, now faces fresh questions amid Trump's imminent return to the presidency.
What Happened: State Judge Juan Merchan granted Trump's request to postpone sentencing to consider arguments about immunity, NBC News <a href="https://www.nbcnews.com/politics/donald-trump/judge-trump-hush-money-case-postpones-sentencing-consider-whether-case-rcna180861">reports</a>. Trump's attorneys assert that the recent Supreme Court decision on presidential protections applies to his conviction, seeking to have the case dismissed entirely. 
Proceedings have been rescheduled, with defense filings due by Dec. 2 and responses from prosecutors by Dec. 9.
Prosecutors acknowledged Trump's status as president-elect presents unprecedented legal questions. According to NBC News, they suggested sentencing could be deferred until the end of his term, citing the need to balance constitutional interests.
Also Read: <a href="https://www.benzinga.com/news/global/24/11/42126727/nate-silver-says-biden-should-resign-have-harris-take-over-presidency-its-a-very-difficult-job">Nate Silver Says Biden Should Resign, Have Harris Take Over Presidency: &#8216;It&#8217;s A Very Difficult Job&#8217;</a>
Why It Matters: The delay underscores the broader implications of presidential immunity, a contentious issue reshaped by recent Supreme Court rulings. As Trump prepares to take office in January, his legal battles highlight the tension between political power and judicial accountability.
Separately, Trump announced the nomination of Pam Bondi as attorney general, replacing Matt Gaetz, who <a href="https://www.benzinga.com/news/24/11/42130207/trump-picks-former-florida-ag-pam-bondi-for-justice-department-after-matt-gaetz-withdraws">withdrew amid ethics concerns. </a>
Bondi, <a href="https://www.benzinga.com/news/legal/24/11/42143770/trumps-pick-for-attorney-general-is-no-matt-gaetz-when-it-comes-to-cannabis-reform">Florida's former attorney genera</a>l and a key figure in Trump's 2020 impeachment defense, is expected to refocus the Department of Justice (DOJ) under the new administration. Trump described the DOJ as "weaponized" and pledged to redirect its priorities.
Read Next:
<ul>
<li> <a href="https://www.benzinga.com/government/regulations/24/11/42144709/kennedys-war-on-food-dyes-could-be-coming-to-your-breakfast-table">Kennedy&#8217;s War On Food Dyes Could Be Coming To Your Breakfast Table</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Politics

Legal

Trump's Hush Money Sentencing Delayed As Legal Immunity Debate Escalates

<h3 class="wp-block-heading">New On The Block</h3>
<ul>
<li>Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) is looking to sell a stake in its Chinese operations. Same-store sales in China fell 14% last quarter, with the Seattle-based coffee retailer seeking partnerships to adapt to tough <a href="https://www.benzinga.com/news/asset-sales/24/11/42117962/starbucks-eyes-stake-sale-in-china-amid-fierce-competition-and-falling-sales">economic and competitive pressures</a>.</li>
</ul>
<h3 class="wp-block-heading">Bankruptcy Block</h3>
<ul>
<li>Snack producer Hearthside Food Solutions went bankrupt. The private equity-owned company looks to offload the $1.9 billion in debt accumulated under the ownership of Partners Group Holding AG and Charlesbank Capital Partners. The two firms bought Hearthside for more than $2.4 billion. Assets and liabilities hover between $1 billion and $10 billion. Last year, bankrupt private equity portfolio companies in the U.S. <a href="https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/private-equity-portfolio-companies-on-track-for-most-bankruptcies-since-2020-74886821">outpaced</a> the number of <a href="https://www.benzinga.com/news/20/10/17861269/bankruptcy-update-ruby-tuesday-files-chapter-11-while-progress-slows-for-jcpenney">bankruptcies in 2020</a>. It remains to be seen whether 2024 will be worse.</li>
</ul>
<ul>
<li>Northvolt <a href="https://northvolt.com/articles/peter-carlsson-steps-aside/">filed</a> for bankruptcy with debt of $5.8 billion. Recall how the Swedish battery maker, which supplies Volkswagen AG&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>) and&nbsp;Bayerische Motoren Werke AG&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMWYY#OTC">BMWYY</a>), bargained with banks to <a href="https://www.benzinga.com/news/23/03/31506581/volkswagen-bmw-battery-supplier-northvolt-eyes-raising-5b-via-debt">raise debt last year</a>. Now, it&#8217;s hoping to restructure under U.S. Chapter 11.</li>
</ul>
See Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42024210/benzinga-bulls-and-bears-tesla-disney-gold-and-hedge-funds-project-bitcoin-to-hit-100k-150k">Benzinga Bulls And Bears: Tesla, Disney, Gold — And Hedge Funds Project Bitcoin To Hit $100K-$150K</a>
<h3 class="wp-block-heading">Updates From The Block</h3>
<ul>
<li>Google&#8216;s $2-billion <a href="https://www.benzinga.com/news/large-cap/23/10/35474706/googles-ai-ambitions-grow-with-major-investment-in-openai-rival-anthropic">investment</a> in Anthropic is in jeopardy, according to <a href="https://www.bloomberg.com/news/articles/2024-11-21/us-justice-department-seeks-to-unwind-google-s-anthropic-deal">Bloomberg</a>. Anthropic is a Jeff Bezos-backed rival to artificial intelligence (AI) innovator OpenAI. The U.S. Department of Justice (DOJ) recommended in <a href="https://www.benzinga.com/tech/24/11/42105079/googles-unlawful-behavior-stifles-market-entry-for-rivals-doj-says-alphabet-must-sell-chrome-to-end-search-monopoly">a court filing Wednesday</a> that Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google divest its Chrome browser to dismantle its monopoly on online search. It doesn&#8217;t end there. Google should be barred from doing any deals with companies that control where consumers search for information, regulators say. <a href="https://www.benzinga.com/tech/24/11/42123646/google-anthropic-deal-in-jeopardy-as-us-justice-department-looks-to-snap-online-search-monopoly">That includes AI products</a>.</li>
</ul>
<ul>
<li>Ricky Williams&#8216; Highsman merges with hemp brand Frozen Fields, forming Top Seed Inc. The partnership blends cannabis and hemp sectors, leveraging R&amp;D to enhance products <a href="https://www.benzinga.com/markets/cannabis/24/11/42097662/ricky-williams-highsman-merges-with-hemp-brand-frozen-fields">and control supply chains</a>.</li>
</ul>
<ul>
<li>MakeMyTrip acquires Happay from CRED. The deal is expected to enhance corporate travel and expense management solutions in India. Happay&#8217;s team will integrate with MakeMyTrip, supporting <a href="https://www.benzinga.com/general/travel/24/11/42039458/makemytrip-agrees-to-acquire-happay-bolstering-its-arsenal-for-corporate-travel-solutions">over 900 clients post-acquisition</a>.</li>
</ul>
<ul>
<li>Amcor plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMCR#NYSE">AMCR</a>) and Berry Global Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BERY#NYSE">BERY</a>) agreed to merge in an all-stock transaction, with the deal valuing Berry stock <a href="https://www.benzinga.com/news/large-cap/24/11/42069248/amcor-and-berry-seal-the-deal-73-59-per-share-merger-to-forge-packaging-powerhouse">at $73.59 per share</a>.</li>
</ul>
<ul>
<li>Nippon Steel (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NISTF#OTC">NISTF</a>) executives have traveled to Pennsylvania to garner support for their $15 billion acquisition bid for U.S. Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>). The Japanese steel giant is encountering political resistance in Washington. Takahiro Mori, vice-chair of Nippon Steel, arrived in Pittsburgh on Saturday to advocate for the acquisition. The deal faces opposition from both President Joe Biden and President-elect Donald Trump, who prefer U.S. Steel to <a href="https://www.benzinga.com/markets/24/11/42056111/nippon-steel-execs-rally-support-in-pennsylvania-amid-pushback-on-us-steel-takeover">remain under American ownership</a>.</li>
</ul>
<h3 class="wp-block-heading">Notes From The Block</h3>
Joshua Robinson, co-founder of Darwin Financial Company, announced a $55-million financing deal with INYOAG LLC. The funds will help develop a solar-powered mine in Inyo County, California where there are proven reserves of silver, lead, zinc, tungsten, and copper. Here&#8217;s our conversation with Robinson:
<h4 class="wp-block-heading">BZ: What is the deal structure between Darwin Financial and base metals miner INYOAG? </h4>
Robinson: The deal structure is a $55M project financing package split into three components: $17.5 million and $12.5 million in six-year notes tied to sulfide and oxide production respectively, plus a $20-million conditional equity commitment that only triggers if the mine hits $10 million in monthly revenue. We get 17% of gross revenues from both production tracks, structured through secure lockbox arrangements. It&#8217;s not a straight equity investment, we specifically designed it this way to provide further upside exposure.
<h4 class="wp-block-heading">Are you looking for additional investors/joint venture partners? </h4>
Yes, we&#8217;ve deliberately structured this to create multiple layers of upside potential, which is pretty unique in the mining space. We&#8217;ve created a hybrid model that offers both near-term cash flow from production and significant expansion potential. We&#8217;re already seeing interest from established mining players, but we&#8217;re particularly excited about bringing new investors into the space who understand the strategic value of critical minerals.
<h4 class="wp-block-heading">What are the downsides to depending on foreign sources of critical minerals?</h4>
China&#8217;s recent actions really highlight the urgency here. They&#8217;ve already implemented export controls on germanium and gallium, and just added antimony to that list. This isn&#8217;t theoretical anymore, it&#8217;s actively happening. We need to build regional resilience in our supply chains, particularly for these minerals that are crucial for defense and technology. The Darwin Mine gives us a unique opportunity to establish a domestic source for multiple critical minerals in a single asset, which is rare to find.
<h4 class="wp-block-heading">Will the mine be powered by solar? </h4>
The 100MW facility wouldn&#8217;t just power the mine. It would generate significant excess clean energy that we can sell back to the grid. What&#8217;s particularly interesting is that we can develop utility-scale energy storage systems using minerals we&#8217;re already producing. It creates a virtuous cycle where our mining operations directly support clean energy deployment
<h4 class="wp-block-heading">What are your 2025 goals?</h4>
For 2025, our key goals are reaching 300 tons per day on sulfide production within six months and 200 tons per day on oxide within nine months of funding. That puts us at $ 10 million in monthly revenue, which then triggers the deeper mine development program.
For last week&#8217;s Deal Dispatch, <a href="https://www.benzinga.com/ma/24/11/42025534/deal-dispatch-shell-unilever-and-more-are-on-the-sell-side-the-onion-makes-alex-jones-cry-foul">click here</a>.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41699259/nvidia-rides-ai-wave-to-replace-intel-on-dow-jones-industrial-average-ending-its-25-year-run">Nvidia Rides AI Wave To Replace Intel On Dow Jones Industrial Average, Ending Its 25-Year Run</a></li>
</ul>
Image: Benzinga

Commodities

Exclusives

Interview

AMCR

BERY

BMWYY

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

GOOG

GOOGL

KRON

MEIP

NISTF

PARA

SAVE

SBUX

SHEL

TSX:SGO

ULCC

VWAGY

Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining

Barrington Research analyst Kevin Steinke maintains ACCO Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACCO#NYSE">ACCO</a>) with a Outperform and raises the price target from $7 to $7.5.

ACCO

Barrington Research Maintains Outperform on ACCO Brands, Raises Price Target to $7.5

NODK

NI Holdings Appointed Seth Daggett As CEO, Appointed Matt Maki As Interim CFO, Both Effective Dec 1, 2024

CARA

Cara Therapeutics Receives Nasdaq Non-Compliance Notice Over Minimum Stockholders' Equity Requirement

Guidance

Quantum-Si Expects That It Will Recognize One-Time Cash Charges Related To Severance And Other Benefits Of ~$2.3M In 2024 And Another $300K In The H1 2025; Expects To Recognize Non-Cash Expense Over The Remainder Of 2024 In The Amount Of ~$200K Related To Stock Option Modifications

Quantum-Si Announces 23% Workforce Reduction As Part Of Restructuring Plan, Expects $2.6M In Severance And Related Costs Through Mid-2025

Organogenesis Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGO#NASDAQ">ORGO</a>), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, announced plans to expand manufacturing capacity with a long-term lease for a 122,000-square foot state-of-the-art biomanufacturing facility located at 100 Technology Way in Smithfield, Rhode Island.

ORGO

Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island

BBIO

Trading Halt: Halted at 4:08:53 p.m. ET - Trading Halt: Halt News Pending

Contracts

JZXN

Jiuzi Holdings And Shenzhen Maigesong Announced They Have Terminated Acquisition Negotiations To Focus On Future Growth

Initial meeting adjourned due to insufficient votes to reach the 50% threshold of outstanding common shares voting in favor of Proposal One and Proposal Two
Stockholders who have not voted are strongly encouraged to vote FOR Proposal One and Proposal Two
NovaBay&#xAE; Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) ("NovaBay" or the "Company") announces that its Special Meeting of Stockholders held on November 22, 2024 has been adjourned until December 18, 2024 at 11:00 a.m. Pacific time to provide stockholders additional time to vote on Proposal One and Proposal Two. Both proposals received significant support based on the shares that have been voted by stockholders but have yet to reach the 50% threshold of favorable votes of all outstanding shares of common stock required to approve each proposal.
<ul>
<li>Proposal One is a proposal to approve the sale of Avenova, representing substantially all of the assets of the Company (the "Asset Sale"), pursuant to the Asset Purchase Agreement, dated September 19, 2024, by and between the Company and PRN Physician Recommended Nutriceuticals, LLC.
<ul>
<li>Proposal Two is a proposal to approve the liquidation and dissolution of the Company, pursuant to the Plan of Complete Liquidation and Dissolution of the Company (the "Plan of Dissolution") which, if approved, would authorize the Company to liquidate and dissolve in accordance with the Plan of Dissolution, and pursuant to the discretion of the Board of Directors to proceed with the dissolution.</li>
</ul>
</li>
</ul>

NovaBay Pharmaceuticals To Reconvene Special Meeting Of Stockholders To December 18, 2024; Initial Meeting Adjourned Due To Insufficient Votes To Reach The 50% Threshold Of Outstanding Common Shares Voting In Favor Of Proposal One And Two

<h3>Gainers</h3>
<ul>
<li>Alta Global Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) shares moved upwards by 25.1% to $2.27 during Friday's pre-market session. The company's market cap stands at $23.7 million. </li>
<li>Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) stock increased by 17.8% to $25.96. The company's market cap stands at $9.7 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) stock moved upwards by 12.38% to $0.8. The market value of their outstanding shares is at $36.6 million. </li>
<li>Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) stock increased by 11.46% to $0.57. The market value of their outstanding shares is at $36.7 million. </li>
<li>Sunlands Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STG#NYSE">STG</a>) shares moved upwards by 8.18% to $7.14. The company's market cap stands at $97.9 million. The company's, Q3 earnings came out today. </li>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) stock moved upwards by 8.1% to $1.6. The company's market cap stands at $6.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cato (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CATO#NYSE">CATO</a>) shares fell 11.3% to $4.4 during Friday's pre-market session. The company's market cap stands at $90.5 million. The company's, Q3 earnings came out yesterday. </li>
<li>Destination XL Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) stock decreased by 6.21% to $2.42. The market value of their outstanding shares is at $140.9 million. As per the press release, Q3 earnings came out today. </li>
<li>Vision Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) stock declined by 6.11% to $2.6. The company's market cap stands at $2.3 million. </li>
<li>Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) shares fell 5.75% to $3.77. The company's market cap stands at $2.3 million. </li>
<li>SAG Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAG#NASDAQ">SAG</a>) stock declined by 5.21% to $2.55. The market value of their outstanding shares is at $25.1 million. </li>
<li>Thunder Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIEV#NASDAQ">AIEV</a>) stock declined by 4.99% to $0.27. The company's market cap stands at $13.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AIEV

ALUR

CATO

DXLG

GDHG

NDLS

TRNR

VMAR

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) stock rose 41.7% to $15.39 during Friday's pre-market session. The company's market cap stands at $33.4 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) stock rose 34.76% to $0.79. The market value of their outstanding shares is at $6.4 million. </li>
<li>Replimune Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REPL#NASDAQ">REPL</a>) stock moved upwards by 23.07% to $13.6. The company's market cap stands at $930.4 million. </li>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFW#NASDAQ">LIFW</a>) shares increased by 20.27% to $1.78. The company's market cap stands at $2.2 million. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) stock rose 12.58% to $3.4. The market value of their outstanding shares is at $2.9 million. As per the press release, Q3 earnings came out today. </li>
<li>IO Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOBT#NASDAQ">IOBT</a>) stock rose 12.56% to $0.77. The company's market cap stands at $50.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) stock decreased by 55.0% to $6.08 during Friday's pre-market session. The company's market cap stands at $7.0 million. </li>
<li>Evotec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NASDAQ">EVO</a>) stock fell 17.01% to $4.44. The company's market cap stands at $1.5 billion. </li>
<li>Procaps Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROC#NASDAQ">PROC</a>) shares decreased by 14.42% to $0.95. The market value of their outstanding shares is at $107.1 million. </li>
<li>BioXcel Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTAI#NASDAQ">BTAI</a>) shares decreased by 8.87% to $0.52. The company's market cap stands at $22.2 million. </li>
<li>Silexion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) shares fell 7.93% to $0.29. The company's market cap stands at $4.2 million. </li>
<li>TruBridge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBRG#NASDAQ">TBRG</a>) shares declined by 7.88% to $14.75. The market value of their outstanding shares is at $220.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMIX

BTAI

IOBT

LIFW

PROC

REPL

SCNI

SLXN

TBRG

VRPX

XCUR

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>SKK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKK#NASDAQ">SKK</a>) shares increased by 75.4% to $1.93 during Friday's pre-market session. The market value of their outstanding shares is at $30.1 million. </li>
<li>Jet AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) stock moved upwards by 39.24% to $8.48. The company's market cap stands at $6.6 million. </li>
<li>Icon Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) stock increased by 23.5% to $2.68. The market value of their outstanding shares is at $4.3 million. </li>
<li>Aqua Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQMS#NASDAQ">AQMS</a>) stock moved upwards by 12.15% to $2.03. The market value of their outstanding shares is at $14.4 million. </li>
<li>Matthews International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATW#NASDAQ">MATW</a>) shares moved upwards by 11.8% to $28.5. The company's market cap stands at $875.2 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Marti Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MRT#AMEX">MRT</a>) stock increased by 11.32% to $2.16. The market value of their outstanding shares is at $123.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Knightscope (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) shares fell 31.1% to $12.61 during Friday's pre-market session. The market value of their outstanding shares is at $48.1 million. </li>
<li>Flux Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLUX#NASDAQ">FLUX</a>) shares declined by 11.82% to $2.09. The company's market cap stands at $34.8 million. </li>
<li>Caravelle Intl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCO#NASDAQ">HTCO</a>) stock fell 9.1% to $1.1. The company's market cap stands at $61.3 million. </li>
<li>L.B. Foster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSTR#NASDAQ">FSTR</a>) shares decreased by 8.33% to $25.0. The company's market cap stands at $270.7 million. </li>
<li>ESGL Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESGL#NASDAQ">ESGL</a>) stock fell 6.78% to $1.63. The market value of their outstanding shares is at $65.5 million. </li>
<li>Satellogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) stock decreased by 5.52% to $1.2. The company's market cap stands at $108.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Cartica Acq

Cartica Acq (CITEW) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga